VanEck Fabless Semiconductor ETF (NASDAQ: SMHX)

에 대한 최신 뉴스 VanEck Fabless Semiconductor ETF (NASDAQ:SMHX)

The Fund normally invests at least 80% of its total assets in securities that comprise the Funds benchmark index. The Fabless Index is composed of U.S.-listed common stocks of companies that derive at least 50% of their revenues from the semiconductor industry and operate as fabless semiconductor companies. A fabless semiconductor company is generally defined as an advanced chip designer without a production line. More specifically, a fabless semiconductor company is engaged in the design and sale of semiconductors and hardware while outsourcing most semiconductor fabrication and product manufacturing. Furthermore, the Fabless Index does not currently include companies engaged in the production of equipment used in the manufacturing of semiconductors or semiconductor materials used in visual displays

VanEck Fabless Semiconductor ETF

Asia

Government

Large Cap

Regulations

Sector ETFs

Global

Tech

ETFs

AOTG

ESPO

FEPI

NVDA

EA Series Trust Strive U.S. Semiconductor ETF

SHOC

SMHX

SOXQ

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

SOXY

워싱턴이 우호적이지 않은 국가들에 대한 반도체 칩 수출 규제를 강화함에 따라 엔비디아(NASDAQ:NVDA)와 어드밴스드 마이크로 디바이시스(NASDAQ:AMD)는 반도체 산업의 글로벌 환경을 혼란에 빠뜨릴 수 있는 지정학적 권력 이동의 한가운데에 있다.

AI 시장을 뒤흔들 바이든의 최종 칩 규제: 엔비디아, AMD에 높은 지분을 가진 10개 ETF

JMP Securities analyst Roy Buchanan reiterates Inovio Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INO#NASDAQ">INO</a>) with a Market Outperform and maintains $18 price target.

News

Price Target

Reiteration

Analyst Ratings

JMP Securities Reiterates Market Outperform on Inovio Pharmaceuticals, Maintains $18 Price Target

Options

Markets

RIVN

Rivian Automotive Option Alert: Feb 21 $18 Calls Sweep (20) near the Ask: 1000 @ $0.45 vs 18125 OI; Earnings 2/20 After Close Ref=$14.14

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains CNA Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNA#NYSE">CNA</a>) with a Market Perform and lowers the price target from $55 to $54.

Keefe, Bruyette & Woods Maintains Market Perform on CNA Financial, Lowers Price Target to $54

Long-term inflation expectations among U.S. consumers have surged to their highest levels since the summer of 2008, raising fresh concerns over the Federal Reserve's ability to <a href="https://www.benzinga.com/news/econ-s">rein in price pressures.</a>
In a report released Friday, the University of Michigan's preliminary consumer sentiment survey for January revealed a notable shift in inflation expectations. 
The year-ahead inflation gauge jumped to 3.3%, up from December's 2.8%, while five-year expectations also rose to 3.3% —marking the sharpest level since June 2008.
<h3 class="wp-block-heading">Consumer Sentiment Little Changed, Inflation Fears Intensify</h3>
The overall consumer sentiment index dipped slightly to 73.2 in January, marginally missing economist forecasts of 73.8 and down from 74 in December. 
This minor decline is overshadowed by the sharp rise in inflation expectations.
&#8220;Consumer sentiment was essentially unchanged in January,&#8221; said Joanne Hsu, director of the University of Michigan&#8217;s Surveys of Consumers. 
She highlighted the alarming increase in inflation expectations across both the short and long term, noting that it was only the third time in four years that such a significant shift had occurred.
&#8220;For both the short and long run, inflation expectations rose across multiple demographic groups, with particularly strong increases among lower-income consumers and Independents,&#8221; Hsu said.
Despite concerns about inflation, the index for current economic conditions improved to 77.9 in January, the highest reading since April 2024 and up from 75.1 in December. This gain was offset by a drop in the consumer expectations index, which fell to 70.2, its lowest point since July 2024.
The broader economic implications of the report are troubling. 
Rising long-term inflation expectations suggest that consumers may believe the Federal Reserve will struggle to bring inflation back to its 2% target, potentially leading to entrenched pricing pressures across the economy.
One possible explanation, not addressed in the report, is that the January&#8217;s University of Michigan survey may already be capturing consumer concerns about the impact of the incoming Trump administration's planned tariff hikes, which could push up prices on goods and services.
<h3 class="wp-block-heading">Markets Extend Losses As Inflation Angst Grows</h3>
Wall Street reacted swiftly to the concerning data, with major indices extending Friday's selloff, which had already been fueled by a <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/42912480/us-economy-adds-256000-payrolls-in-december-as-tight-labor-market-tops-forecasts-dollar-treasury-yields-spike">surprisingly strong jobs report. </a>
The S&amp;P 500, tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), fell 1.5% by 10:15 a.m. in New York trading to drop below the 5,800-point mark. The index has now erased all gains made during the post-election rally.
The Dow Jones Industrial Average also slipped 1.4%, touching its lowest levels since early November, while the Nasdaq 100, represented by the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), plummeted 1.8%. Small-cap stocks, measured by the Russell 2000 index, tumbled 1.9%, hitting a three-month low.
Sector performance was broadly negative, with energy stocks being the sole exception. Rising crude oil prices, fueled by tightening U.S. sanctions on Russia, bolstered the sector. West Texas Intermediate crude –—as tracked by the United States Oil Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USO#NYSE">USO</a>) — surged over 4%, reaching $77 a barrel.
Gold, often seen as a safe haven during periods of uncertainty, gained 0.8% as investors sought protection against both inflationary pressures and growing geopolitical risks.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42912208/delta-stock-jumps-after-record-q4-earnings-and-strong-2025-outlook">Delta Takes Flight As Q4 Earnings Beat Expectations, Fueled By Premium Travel Demand And Efficiency Gains</a></li>
</ul>
Photo via Shutterstock.

Equities

Macro Economic Events

Broad U.S. Equity ETFs

Econ #s

Economics

Federal Reserve

Consumer Inflation Worries Highest Since 2008, U Of M Survey Says: Wall Street Tumbles To 2-Month Lows

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Chubb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) with a Outperform and raises the price target from $320 to $328.

Keefe, Bruyette & Woods Maintains Outperform on Chubb, Raises Price Target to $328

Market Summary

General

Benzinga Market Summary: Nonfarm Payroll Additions Exceed Estimates, Goldman Downgrades AMD, 10-Year Rises

JMP Securities analyst Mitch Germain reiterates Getty Realty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTY#NYSE">GTY</a>) with a Market Outperform and maintains $34 price target.

JMP Securities Reiterates Market Outperform on Getty Realty, Maintains $34 Price Target

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Baldwin Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWIN#NASDAQ">BWIN</a>) with a Outperform and lowers the price target from $50 to $49.

BWIN

Keefe, Bruyette & Woods Maintains Outperform on Baldwin Insurance, Lowers Price Target to $49

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) with a Underperform and lowers the price target from $99 to $97.

Keefe, Bruyette & Woods Maintains Underperform on Brown & Brown, Lowers Price Target to $97

Taiwan Semiconductor Manufacturing Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) is riding a wave of positive momentum as it gears up for its <a href="https://www.benzinga.com/quote/TSM/earnings">fourth quarter earnings release</a> on Jan. 16.
<h2 class="wp-block-heading">An Impressive 57.8% YoY Revenue Increase</h2>
The semiconductor giant <a href="https://pr.tsmc.com/system/files/newspdf/attachment/60197ea6bf066bbdecf152f28fa32cd83151adfb/Dec%202024%20%28E%29_final_wmn.pdf">reported</a> December 2024 net revenue of NT$278.16 billion (approx. $8.44 billion), marking a 57.8% year-over-year increase and cementing a 33.9% annual revenue growth over 2023.
Despite the tech sector&#8217;s recent turbulence, TSM stock has posted impressive gains: up 7.91% over the past month and 5.03% in just the past five days. 
With Wall Street projecting fourth quarter EPS at $2.19 and revenue around $26.19 billion, according to data from <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">Benzinga Pro</a>, investors have their eyes set on another potential blockbuster quarter.
Read More: <a href="https://www.benzinga.com//node/42907937">Taiwan Semiconductor Hits $26.3 Billion Q4 Revenue, Reportedly Ends PowerAIR Deal Over Huawei Chip Breach Amid US Sanctions</a>
<h2 class="wp-block-heading">TSM Stock Chart Paints A Bullish Picture</h2>
The technical landscape paints a bullish picture for TSM stock. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="630" height="494" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10083527/Screenshot-2025-01-10-at-7.05.05-PM.png" alt="" class="wp-image-728086" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10083527/Screenshot-2025-01-10-at-7.05.05-PM.png 630w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/10083527/Screenshot-2025-01-10-at-7.05.05-PM-300x235.png 300w" sizes="(max-width: 630px) 100vw, 630px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent011025&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
TSM stock, at $206.17, sits comfortably above its key moving averages:
<ul>
<li>Eight-day SMA: $206.60</li>
<li>20-day SMA: $202.39</li>
<li>50-day SMA: $196.53</li>
<li>200-day SMA: $172.56</li>
</ul>
These signals, coupled with an MACD (moving average convergence/divergence) indicator of 3.82 and an RSI (relative strength index) of 54.07, make TSM stock&#8217;s technical case strongly bullish.
<h2 class="wp-block-heading">TSM Earnings, Growth Outlook</h2>
Analysts remain optimistic about TSM's continued market leadership in advanced chip manufacturing despite broader industry challenges. 
The company's strong revenue performance in December underscores resilience and market dominance. The semiconductor sector has faced a rocky road, but TSM appears positioned to weather the storm with robust fundamentals.
With the fourth quarter earnings looming and TSM maintaining its bullish momentum, market watchers will be keen to see if the company delivers results that justify its recent surge — or if there&#8217;s a plot twist in store for the chip leader.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/01/42897081/nvidia-and-ai-chip-stocks-brace-for-impact-as-biden-administration-considers-new-china-export-ban-report">Nvidia and AI Chip Stocks Brace for Impact as Biden Administration Considers New China Export Ban: Report</a></li>
</ul>
Photo by Jack Hong via Shutterstock

Long Ideas

Technicals

Trading Ideas

TSMC Powers Up: December Revenue Soars Ahead Of Q4 Earnings Release

JMP Securities analyst Chris Muller reiterates Granite Point Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPMT#NYSE">GPMT</a>) from Market Perform to Market Perform.

GPMT

JMP Securities Reiterates Market Perform on Granite Point Mortgageto Market Perform

Keefe, Bruyette &amp; Woods analyst Meyer Sheilds maintains Bowhead Specialty Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOW#NYSE">BOW</a>) with a Market Perform and raises the price target from $36 to $44.

Keefe, Bruyette & Woods Maintains Market Perform on Bowhead Specialty Holding, Raises Price Target to $44

Jefferies analyst Stephanie Moore upgrades Canadian National Railway (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) from Hold to Buy and announces $120 price target.

Upgrades

Jefferies Upgrades Canadian National Railway to Buy, Announces $120 Price Target

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Axis Capital Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXS#NYSE">AXS</a>) with a Outperform and raises the price target from $108 to $110.

Keefe, Bruyette & Woods Maintains Outperform on Axis Capital Holdings, Raises Price Target to $110

MIND C.T.I. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDO#NASDAQ">MNDO</a>) announced on Friday that it has signed a definitive agreement to acquire Aurenz GmbH, a provider of Unified Communications (UC) analytics <a href="https://www.benzinga.com/premarket" target="_blank" rel="noreferrer noopener">and call accounting solutions in Germany.</a>
The acquisition, valued at approximately $1.88 million in cash, strengthens MIND&#8217;s position in the unified communications analytics market, which provides critical data-driven insights to help organizations optimize their communication strategies.
Founded in 1983, Aurenz is a key player in call accounting and UC analytics.
The company will integrate into UC implementations, offering real-time feedback and insights that help businesses improve response times, resolve issues quickly, and enhance customer service interactions.
Also Read: <a target="_blank" href="https://www.benzinga.com/economics/macro-economic-events/25/01/42912480/us-economy-adds-256000-payrolls-in-december-as-tight-labor-market-tops-forecasts-dollar-treasury-yields-spike" rel="noreferrer noopener">US Economy Adds 256,000 Payrolls In December, Tight Labor Market Tops Forecasts: Dollar, Treasury Yields Spike</a>
As part of the acquisition, Jürgen Dagutat, Managing Director of Aurenz, will continue to lead the company, ensuring continuity and strengthening existing partnerships.
The acquisition is expected to be accretive to MIND&#8217;s earnings per share in fiscal 2025 and beyond, with the results of Aurenz to be consolidated starting in the first quarter of 2025.
Ariel Glassner, CEO of MIND, expressed confidence that the acquisition would bolster MIND&#8217;s position as a provider of UC analytics, especially in the European market.
Glassner highlighted the complementary strengths of both companies and emphasized that the acquisition aligns with MIND&#8217;s strategy of leveraging its cash position and experienced team to respond to market needs while maintaining its dividend policy.
The acquisition is set to be completed shortly, subject to customary closing requirements.
Price Action: MNDO shares are trading flat at $2.02 at last check Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/01/42907937/taiwan-semiconductor-hits-26-3-billion-q4-revenue-reportedly-ends-powerair-deal-over-huawei-chip-breach-amid-us-sanctions" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor Hits $26.3 Billion Q4 Revenue, Reportedly Ends PowerAIR Deal Over Huawei Chip Breach Amid US Sanctions</a></li>
</ul>
Image via Shutterstock.

MNDO

MIND CTI Expands European Footprint With $1.88M Aurenz Acquisition: Details

<a href="https://apnews.com/live/trump-sentencing-hush-money-new-york-updates#https://apnews.com/live/trump-sentencing-hush-money-new-york-updates" title="https://apnews.com/live/trump-sentencing-hush-money-new-york-updates#https://apnews.com/live/trump-sentencing-hush-money-new-york-updates">https://apnews.com/live/trump-sentencing-hush-money-new-york-updates#https://apnews.com/live/trump-sentencing-hush-money-new-york-updates</a>

Politics

Legal

'Judge Sentences Trump In Hush Money Case But Declines To Impose Any Punishment' - AP

As of Jan. 10, 2025, two stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Sana Biotechnology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>)</h3>
<ul>
<li>On Tuesday, Sana Biotechnology released the initial results from a first-in-human study transplanting UP421, an allogeneic primary islet cell therapy engineered with Sana's hypoimmune (HIP) technology, into a type 1 diabetes patient without the use of any immunosuppression. The study was conducted in partnership with Uppsala University Hospital. The company's stock surged around 162% over the past five days and has a <a href="https://www.benzinga.com/quote/SANA">52-week high of $12.00</a>.</li>
<li>RSI Value: 73.4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>SANA Price Action: Shares of Sana Biotechnology closed at $4.30 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Mesoblast Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESO#NASDAQ">MESO</a>)</h3>
<ul>
<li>On Dec. 19, Mesoblast announced the U.S. Food and Drug Administration (FDA) approved Ryoncil. Ryoncil is the first FDA approved therapy for children aged 2 months and older with steroid-refractory acute graft versus host disease (SR-aGvHD).. The company's stock gained around 53% over the past month and <a href="https://www.benzinga.com/quote/MESO">has a 52-week high</a> of $22.00.</li>
<li>RSI Value: 77.8</li>
<li>MESO Price Action: Shares of Mesoblast fell 4% to close at $17.18 on Wednesday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42900074/how-to-earn-500-a-month-from-synovus-financial-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Synovus Financial Stock Ahead Of Q4 Earnings</a></li>
</ul>

Short Ideas

MESO

SANA

Top 2 Health Care Stocks That Are Ticking Portfolio Bombs

Allianz Investment Management launched two innovative funds for a streamlined approach to risk management. The AllianzIM 6 Month Buffer10 Allocation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPBX#NYSE">SPBX</a>) and AllianzIM Buffer20 Allocation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPBW#NYSE">SPBW</a>) provide a laddered strategy, helping investors navigate unpredictable markets without the timing pitfalls often associated with buffered ETFs.
The concept of laddering isn't new to traditional investment portfolios, but applying it to buffered ETFs is a fresh strategy. These funds allow investors to reap the benefits of capped upside returns while providing downside protection, making them ideal during volatility in the markets.
Also See: <a href="https://www.benzinga.com/etfs/new-etfs/25/01/42884245/alger-launches-russell-innovation-etf-to-capitalize-on-emerging-innovators">Alger Launches Russell Innovation ETF To Capitalize On Emerging Innovators</a>
Both SPBX and SPBW invest in portfolios of existing AllianzIM ETFs but take advantage of staggered outcome periods. SPBX consists of six AllianzIM U.S. Large Cap 6 Month Buffer10 ETFs, each offering a six-month outcome period with a 10% downside buffer. SPBW, on the other hand, comprises a dozen AllianzIM U.S. Large Cap Buffer20 ETFs, each operating on a one-year outcome period with a 20% downside buffer. 
This laddered structure eliminates the need to track multiple funds and ensures a seamless transition from one outcome period to the next. The funds carry competitive net expense ratios of 0.79%.
Buffered ETFs have been gaining traction for their ability to limit losses. However, their success often depends on cap timing — a challenge these laddered portfolios aim to do away with.
The launch of SPBX and SPBW adds to AllianzIM's success in the buffered ETF space, where funds like the AllianzIM U.S. Large Cap Buffer20 Jan ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JANW#NYSE">JANW</a>) have already shown robust growth, with $200 million in net flows in a month alone, as of Jan. 6. 
See Next:
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/01/42898157/feds-cautious-rate-cut-approach-boosts-appeal-of-these-3-etfs">Fed&#8217;s Cautious Rate Cut Approach Boosts Appeal Of These 3 ETFs</a></li>
</ul>
Photo: Shutterstuck

New ETFs

JANW

AIM ETF Products Trust AllianzIM Buffer20 Allocation ETF

SPBW

AIM ETF Products Trust AllianzIM 6 Month Buffer10 Allocation ETF

SPBX

AllianzIM Pioneers Risk-Managed Investment, Launches Two Laddered Buffer ETFs

AMC Enter Hldgs's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMC#NYSE">AMC</a>) short percent of float has risen 7.31% since its last report. The company recently reported that it has 53.05 million shares sold short, which is 13.94% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.53 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>AMC Enter Hldgs Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736523021_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AMC Enter Hldgs has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing AMC Enter Hldgs's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, AMC Enter Hldgs's peer group average for short interest as a percentage of float is 7.73%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

(AMC) - Analyzing AMC Enter Hldgs's Short Interest

Cigna's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) short percent of float has risen 44.35% since its last report. The company recently reported that it has 4.61 million shares sold short, which is 1.66% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.91 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Cigna Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736523016_0_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cigna has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Cigna's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Cigna's peer group average for short interest as a percentage of float is 6.25%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Cigna's Recent Short Interest

Fabless Chip Designers: Shaping The Future Of Semiconductors

Semiconductor ETFs: Not-So-Shocking Growth

Fabless Semiconductor Companies: The Brains Behind Edge Computing

Tech Investing In 2025: Emerging Trends And Market Opportunities

AVGO

FTXL

INTC

MRVL

NVDL

QCOM

SEMI

SOXL

SOXS

Press Releases

VanEck Launches SMHX: Targeted Exposure To Fabless Semiconductor Designers

VanEck Announces Year-End Distributions for VanEck Equity ETFs

BUZZ

CNXT

CRAK

DAPP

DESK

DGIN

EINC

GDXJ

GLIN

GMET

IBOT

ISRA

LFEQ

RAAX

REMX

RNEW

SMOG

워싱턴이 우호적이지 않은 국가들에 대한 반도체 칩 수출 규제를 강화함에 따라 엔비디아(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)와 어드밴스드 마이크로 디바이시스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>)는 반도체 <a href="https://www.benzinga.com/topic/semiconductors" target="_blank" rel="noopener">산업의 글로벌 환경</a>을 혼란에 빠뜨릴 수 있는 지정학적 권력 이동의 한가운데에 있다.
월요일에 공유된 블룸버그의 보고서에 따르면, 바이든 행정부는 <a href="https://www.benzinga.com/government/regulations/25/01/42897081/nvidia-and-ai-chip-stocks-brace-for-impact-as-biden-administration-considers-new-china-export-ban-report" target="_blank" rel="noopener">고급 반도체를 겨냥한</a> 새로운 수출 규정을 곧 발표할 예정이다.
이번 주 금요일 발표될 새로운 조치는 고성능 컴퓨팅 칩에 대한 접근을 제한함으로써 중국의 기술 및 군사 발전을 저지하려는 미국의 전략적 노력을 강화한다.
<h3 class="wp-block-heading">새로운 AI 수출 프레임워크: 동맹과 적</h3>
이 규정은 반도체 수출에 대한 3단계 구조를 만들고, 주요 미국 동맹국, 중립 국가 및 제한 국가에 대한 접근 수준을 강조할 것으로 보인다.
중국은 러시아, 이란 및 베네수엘라와 함께 가장 엄격한 단계에 포함될 것으로 예상된다.
이 단계별 프레임워크는 제한 국가들의 특정 기업들이 미국의 보안 프로토콜과 인권 기준에 동의하면 국가적 한계를 우회할 수 있도록 한다.
이러한 기관들은 검증된 최종 사용자들로 지정되어 칩 구매 한도가 높아지며, 이는 전 세계적으로 안전한 인공지능(AI) 개발을 장려하기 위한 조치이다.
이번 조치는 이미 2022년 10월에 시행된 광범위한 수출 제한을 확장한 것으로, 당시에는 엔비디아의 호퍼(Hopper) GPU와 같은 고급 AI 칩의 판매가 제한되었다.
이전 규정은 미국 기업들과 개인들이 중국 칩 개발을 지원하는 것을 명시적인 정부 승인 없이 금지했다.
<h3 class="wp-block-heading">엔비디아와 AMD에 대한 집중 조사</h3>
엔비디아의 A800 및 H800 칩은 이전 규정을 준수하기 위해 개발되었지만, 새로운 제한에 적용될 경우 AI 거인의 향후 매출에 타격을 줄 수 있다.
데이터 회사인 팩트셋(FactSet)에 따르면, 중국은 엔비디아의 매출에서 약 16%를 차지하며, 이는 회사의 두 번째로 큰 시장이다. 이는 2022년 수출 제한 이전의 25%에서 감소한 수치이다.
2023년에는 AMD가 중국(홍콩 포함)에서 약 34억 달러의 매출을 올렸으며, 이는 회사의 총 매출 227억 달러의 15%를 차지한다.
<h3 class="wp-block-heading">엔비디아와 AMD에 관련된 주요 ETF</h3>
엔비디아와 AMD에 크게 노출된 여러 ETF가 영향을 받을 수 있다:
엔비디아를 보유한 주요 ETF (보유 비율):
<ul>
<li>ProShares Ultra Semiconductors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USD#NYSE">USD</a>): 34.96%</li>
<li>Strive U.S. Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHOC#NASDAQ">SHOC</a>): 21.10%</li>
<li>YieldMax Target 12 Semiconductor Option (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXY#NASDAQ">SOXY</a>): 20.50%</li>
<li>VanEck Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMH#NASDAQ">SMH</a>): 20.21%</li>
<li>VanEck Fabless Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMHX#NASDAQ">SMHX</a>) – 20.11%</li>
</ul>
AMD를 보유한 주요 ETF (보유 비율):
<ul>
<li>VanEck Video Gaming and Esports ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPO#NASDAQ">ESPO</a>): 8.01%</li>
<li>iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>): 7.12%</li>
<li>AOT Growth and Innovation ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOTG#NASDAQ">AOTG</a>): 7.07%</li>
<li>Invesco PHLX Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXQ#NASDAQ">SOXQ</a>): 7.04%</li>
<li>REX FANG &amp; Innovation Equity ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEPI#NASDAQ">FEPI</a>): 6.95%</li>
</ul>
다음 읽어보기: 
<ul>
<li><a href="https://kr.benzinga.com/news/usa/stocks/%EA%B3%A8%EB%93%9C%EB%A7%8C%EC%82%AD%EC%8A%A4-%EC%9D%B8%ED%94%8C%EB%A0%88%EC%9D%B4%EC%85%98%EA%B3%BC-%ED%8A%B8%EB%9F%BC%ED%94%84-%EC%A0%95%EC%B1%85-%EB%B6%88%ED%99%95%EC%8B%A4%EC%84%B1-%EC%86%8D/" target="_blank" rel="noopener">골드만삭스, 인플레이션 및 트럼프 정책으로 인한 불확실성으로 시장 조정 리스크 경고</a></li>
</ul>
이미지는 Shutterstock의 사진을 사용하여 생성되었습니다.


Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

Comments

VanEck Fabless Semiconductor ETF

뉴스

에 대한 최신 뉴스 VanEck Fabless Semiconductor ETF (NASDAQ:SMHX)

목요일, 1월 09, 2025

뉴스

파트너 / 기고자

벤징가 글로벌